October 28, 2020 at 05:30AM
As access to vaccines becomes a global public requirement, how such vaccines can be effectively traded across borders to reach people needs to be discussed. The problem will assume huge proportions if the flexibilities in the current WTO IP rules do not allow producers, particularly from developing countries, to bypass IP restrictions
from The Financial Express
0 Comments